Inhibitory Effects of Terminalia chebula Extract on Glycation and Endothelial Cell Adhesion
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Hyun-Sun | - |
dc.contributor.author | Cho, Hong Yon | - |
dc.contributor.author | Park, Kuen-Woo | - |
dc.contributor.author | Kim, In-Hwan | - |
dc.contributor.author | Kim, Jong-Tak | - |
dc.contributor.author | Nam, Mi-Hyun | - |
dc.contributor.author | Lee, Kwang-Won | - |
dc.date.accessioned | 2021-09-07T11:13:45Z | - |
dc.date.available | 2021-09-07T11:13:45Z | - |
dc.date.created | 2021-06-14 | - |
dc.date.issued | 2011-07 | - |
dc.identifier.issn | 0032-0943 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/112157 | - |
dc.description.abstract | Terminalia chebula Retz. has been used in India for a long time to treat many diseases, and its extract was reported to have antidiabetic activity in vivo. In this study, T. chebula methanolic extract (TCE) containing 2.7% chebulic acidwas evaluated for its preventive effects against the formation of advanced glycation end products (AGEs) and endothelial cell dysfuction. When the effects of TCE on AGE formation and on protein crossing-linking by glycation with D-threose and lens crystallines were examined, TCE showed inhibitory activity in a dose-dependent manner, and the concentration of 1000 mu g/mL presented an activity similar to that of 5 mM aminoguanidine as a positive control. Upon investigating the protective activity of TCE against AGE-induced vascular endothelium dysfunction, human umbilical vein endothelial cells (HUVEC) incubated with 100 mu g/mL of AGEs had significantly enhanced reactive oxygen species (ROS) formation, whereas the treatment of T. chebula reduced AGE-induced ROS generation. The incubation of HUVEC with 100 mu g/mL of AGEs caused a considerable increase in THP-1 monocytic cell adhesion, but this adhesion was reduced by the treatment of TCE. These results suggest that TCE is a potential agent for alleviating diabetic complications. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | GEORG THIEME VERLAG KG | - |
dc.subject | IN-VITRO | - |
dc.subject | DIABETIC COMPLICATIONS | - |
dc.subject | MAILLARD REACTION | - |
dc.subject | AMINOGUANIDINE | - |
dc.subject | HYPERGLYCEMIA | - |
dc.subject | ENDPRODUCTS | - |
dc.subject | MECHANISMS | - |
dc.subject | RATS | - |
dc.subject | THERAPIES | - |
dc.subject | DISEASES | - |
dc.title | Inhibitory Effects of Terminalia chebula Extract on Glycation and Endothelial Cell Adhesion | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Cho, Hong Yon | - |
dc.contributor.affiliatedAuthor | Kim, In-Hwan | - |
dc.contributor.affiliatedAuthor | Lee, Kwang-Won | - |
dc.identifier.doi | 10.1055/s-0030-1270748 | - |
dc.identifier.scopusid | 2-s2.0-79959992844 | - |
dc.identifier.wosid | 000292249500013 | - |
dc.identifier.bibliographicCitation | PLANTA MEDICA, v.77, no.10, pp.1060 - 1067 | - |
dc.relation.isPartOf | PLANTA MEDICA | - |
dc.citation.title | PLANTA MEDICA | - |
dc.citation.volume | 77 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1060 | - |
dc.citation.endPage | 1067 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Plant Sciences | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Integrative & Complementary Medicine | - |
dc.relation.journalWebOfScienceCategory | Plant Sciences | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Integrative & Complementary Medicine | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | IN-VITRO | - |
dc.subject.keywordPlus | DIABETIC COMPLICATIONS | - |
dc.subject.keywordPlus | MAILLARD REACTION | - |
dc.subject.keywordPlus | AMINOGUANIDINE | - |
dc.subject.keywordPlus | HYPERGLYCEMIA | - |
dc.subject.keywordPlus | ENDPRODUCTS | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | RATS | - |
dc.subject.keywordPlus | THERAPIES | - |
dc.subject.keywordPlus | DISEASES | - |
dc.subject.keywordAuthor | Terminalia chebula Retz. | - |
dc.subject.keywordAuthor | Combretaceae | - |
dc.subject.keywordAuthor | advanced glycation end products | - |
dc.subject.keywordAuthor | diabetic complications | - |
dc.subject.keywordAuthor | antioxidant | - |
dc.subject.keywordAuthor | lens crystalline | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.